Logo image of PAVS

PARANOVUS ENTERTAINMENT TECH (PAVS) Stock Fundamental Analysis

USA - NASDAQ:PAVS - KYG4289N2050 - Common Stock

0.614 USD
-0.02 (-2.54%)
Last: 10/22/2025, 6:56:55 PM
0.6149 USD
+0 (+0.15%)
After Hours: 10/22/2025, 6:56:55 PM
Fundamental Rating

1

PAVS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 33 industry peers in the Personal Care Products industry. PAVS may be in some trouble as it scores bad on both profitability and health. PAVS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PAVS has reported negative net income.
PAVS had a negative operating cash flow in the past year.
In the past 5 years PAVS reported 4 times negative net income.
PAVS had negative operating cash flow in 4 of the past 5 years.
PAVS Yearly Net Income VS EBIT VS OCF VS FCFPAVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

PAVS's Return On Assets of -22.19% is on the low side compared to the rest of the industry. PAVS is outperformed by 87.88% of its industry peers.
PAVS has a Return On Equity of -32.54%. This is in the lower half of the industry: PAVS underperforms 75.76% of its industry peers.
Industry RankSector Rank
ROA -22.19%
ROE -32.54%
ROIC N/A
ROA(3y)-116.95%
ROA(5y)-80.13%
ROE(3y)-232.91%
ROE(5y)-152.18%
ROIC(3y)N/A
ROIC(5y)N/A
PAVS Yearly ROA, ROE, ROICPAVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 12.57%, PAVS is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PAVS has declined.
PAVS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.8%
GM growth 5Y-23.08%
PAVS Yearly Profit, Operating, Gross MarginsPAVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

PAVS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PAVS has been increased compared to 1 year ago.
Compared to 5 years ago, PAVS has more shares outstanding
Compared to 1 year ago, PAVS has a worse debt to assets ratio.
PAVS Yearly Shares OutstandingPAVS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PAVS Yearly Total Debt VS Total AssetsPAVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

PAVS has an Altman-Z score of -0.70. This is a bad value and indicates that PAVS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.70, PAVS is doing worse than 90.91% of the companies in the same industry.
PAVS has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
PAVS has a better Debt to Equity ratio (0.01) than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -0.7
ROIC/WACCN/A
WACC7.44%
PAVS Yearly LT Debt VS Equity VS FCFPAVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.12 indicates that PAVS should not have too much problems paying its short term obligations.
PAVS has a Current ratio of 1.12. This is in the lower half of the industry: PAVS underperforms 72.73% of its industry peers.
PAVS has a Quick Ratio of 1.02. This is a normal value and indicates that PAVS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.02, PAVS is doing worse than 60.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.02
PAVS Yearly Current Assets VS Current LiabilitesPAVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 95.95% over the past year.
Looking at the last year, PAVS shows a very negative growth in Revenue. The Revenue has decreased by -98.86% in the last year.
Measured over the past years, PAVS shows a very negative growth in Revenue. The Revenue has been decreasing by -74.40% on average per year.
EPS 1Y (TTM)95.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.11%
Revenue 1Y (TTM)-98.86%
Revenue growth 3Y-90.72%
Revenue growth 5Y-74.4%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAVS Yearly Revenue VS EstimatesPAVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2025 20M 40M 60M 80M
PAVS Yearly EPS VS EstimatesPAVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 5 10 15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAVS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAVS Price Earnings VS Forward Price EarningsPAVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVS Per share dataPAVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PAVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARANOVUS ENTERTAINMENT TECH

NASDAQ:PAVS (10/22/2025, 6:56:55 PM)

After market: 0.6149 +0 (+0.15%)

0.614

-0.02 (-2.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.35M
Revenue(TTM)71.60K
Net Income(TTM)-7893300
Analysts82.86
Price TargetN/A
Short Float %0.07%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 577.47
P/FCF N/A
P/OCF N/A
P/B 1.7
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.36
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.19%
ROE -32.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.57%
FCFM N/A
ROA(3y)-116.95%
ROA(5y)-80.13%
ROE(3y)-232.91%
ROE(5y)-152.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.8%
GM growth 5Y-23.08%
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.02
Altman-Z -0.7
F-Score4
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.86%
Revenue growth 3Y-90.72%
Revenue growth 5Y-74.4%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.63%
OCF growth 3YN/A
OCF growth 5YN/A